Jane Eagleson

Corporate Officer/Principal at Bleecker Street Consulting

73 year

Health Technology

Consumer Services

Process Industries

Profile

Jane Eagleson is the owner of Bleecker Street Consulting.
She previously worked as Senior Director-Asian Business Development at Pfizer Inc., Independent Director at Zomedica Corp., Head-Growth Strategies at Argenta Ltd., Vice President-Clinical & Regulatory Affairs at Nexvet Australia Pty Ltd., and Vice President of Clinical & Regulatory Affairs at Nexvet US, Inc. She received an undergraduate degree from The University of Sydney and a graduate degree from Massey University.

Jane Eagleson active positions

Companies	Position	Start
Bleecker Street Consulting Bleecker Street Consulting Agricultural Commodities/MillingProcess Industries Bleecker Street Consulting provides advice and assistance in the selection, development, and registration of animal health pharmaceutical products. The private company is based in New York, NY.	Corporate Officer/Principal	-

All active positions of Jane Eagleson

Former positions of Jane Eagleson

Companies	Position	End
Argenta Ltd. Argenta Ltd. BiotechnologyHealth Technology Argenta Ltd. operates as a pharmaceutical contract manufacturing company. It serves animal health research, veterinary, and GMP manufacting. The company was founded by Douglas Robert Cleverly in 2006 and is headquartered in Manurewa, New Zealand.	Corporate Officer/Principal	-
Nexvet US, Inc. Nexvet US, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Zoetis, Inc., Nexvet US, Inc. engages in biological research. The company is based in San Francisco, CA.	Chief Tech/Sci/R&D Officer	-
Nexvet Australia Pty Ltd. Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia.	General Counsel	-
PFIZER, INC.	Corporate Officer/Principal	-
ZOMEDICA CORP.	Director/Board Member	-

See the detail of Jane Eagleson's experience

Training of Jane Eagleson

Massey University	Graduate Degree
The University of Sydney	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies